Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.
暂无分享,去创建一个
Don C Des Jarlais | Anastasios Panopoulos | Lucas Wiessing | Angelos Hatzakis | Dimitrios Paraskevis | Samuel R Friedman | Vana Sypsa | D. D. Des Jarlais | D. Heckathorn | A. Pharris | A. Hatzakis | S. Friedman | Anastasios P. Panopoulos | D. Paraskevis | G. Nikolopoulos | M. J. van de Laar | V. Sypsa | M. Donoghoe | L. Wiessing | M. Psichogiou | Martin Donoghoe | Georgios Nikolopoulos | Chrissa Tsiara | Katerina Micha | Meni Malliori | Mina Psichogiou | Anastasia Pharris | Marita van de Laar | Douglas D Heckathorn | M. Malliori | C. Tsiara | K. Micha
[1] A. Lansky,et al. Assessing the Assumptions of Respondent-Driven Sampling in the National HIV Behavioral Surveillance System among Injecting Drug Users , 2012, The open AIDS journal.
[2] D. D. Des Jarlais,et al. Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? , 2014, Annals of epidemiology.
[3] A. Pharris,et al. Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe? , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[4] A. Hatzakis,et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] R. Booth,et al. Gender differences between predictors of HIV status among PWID in Ukraine. , 2014, Drug and alcohol dependence.
[6] D. Heckathorn. 6. Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment , 2007 .
[7] J. Parry,et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment , 2006, AIDS.
[8] D. Heckathorn,et al. Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.
[9] Hongyun Fu,et al. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces , 2014, Harm Reduction Journal.
[10] H. Mills,et al. HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia. , 2013, Drug and alcohol dependence.
[11] R. Rothenberg,et al. Sociometric risk networks and risk for HIV infection. , 1997, American journal of public health.
[12] A. Hatzakis,et al. Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study , 2013, PloS one.
[13] K. Dolan,et al. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. , 1989, AIDS care.
[14] M. Kals,et al. Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia , 2013, AIDS and Behavior.
[15] Dennis P. Culhane,et al. Homelessness and HIV risk behaviors among injection drug users , 2004, Journal of Urban Health.
[16] R. Écochard,et al. Age at Which HIV Infection Can Be Detected in Infants: Place of the Yakovlev Model , 2006, Journal of acquired immune deficiency syndromes.
[17] Don C Des Jarlais,et al. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. , 2002, Journal of acquired immune deficiency syndromes.
[18] A. Hatzakis,et al. HIV epidemiology in Greece. , 2008, Future microbiology.
[19] R. Garfein,et al. HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010 , 2012, The American journal of drug and alcohol abuse.
[20] Patrick S Sullivan,et al. Behavioral Surveillance among People at Risk for HIV Infection in the U.S.: The National HIV Behavioral Surveillance System , 2007, Public health reports.
[21] A. Pharris,et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] A. Uusküla,et al. The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[23] J. Desenclos,et al. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. , 1993, AIDS.
[24] A. Hatzakis,et al. Managing opioid dependence treatment and controlling for HIV incidence among injecting drug users in Greece: a case study of optimism in the face of adversity. , 2013, Addiction.
[25] N. Nurjannah,et al. HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs , 2012, Harm Reduction Journal.
[26] M. Zunzunegui,et al. Women, drugs and HIV/AIDS: results of a multicentre European study. , 2000, International journal of epidemiology.
[27] Matthew J. Salganik. Variance Estimation, Design Effects, and Sample Size Calculations for Respondent-Driven Sampling , 2006, Journal of Urban Health.
[28] G. Rutherford,et al. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. , 2014, The International journal on drug policy.
[29] D. Raoult,et al. Infections in the homeless. , 2001, The Lancet. Infectious diseases.
[30] R. Garfein,et al. Housing Status and Associated Differences in HIV Risk Behaviors Among Young Injection Drug Users (IDUs) , 2007, AIDS and Behavior.
[31] Matthew Hickman,et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia , 2002, AIDS.
[32] M. Zunzunegui,et al. Determinants of HIV prevalence amongst female IDU in Madrid , 2004, European Journal of Epidemiology.
[33] D. D. Jarlais,et al. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. , 2015, American journal of public health.
[34] K. Dolan,et al. Life-style factors and social circumstances of syringe sharing in injecting drug users. , 1992, British journal of addiction.
[35] Mohsen Malekinejad,et al. Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: A Systematic Review , 2008, AIDS and Behavior.
[36] Douglas D. Heckathorn,et al. Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .
[37] E. Regidor,et al. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. , 2012, Addiction.
[38] D. Celentano,et al. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. , 2013, Drug and alcohol dependence.
[39] Douglas D. Heckathorn,et al. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hi , 2002 .
[40] O. Levina,et al. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study , 2013, BMJ Open.
[41] Julio S. G. Montaner,et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.